Company earnings for the 4th quarter of 2016 showed an uptick in sales of contraceptive intrauterine (IUD) devices. The financial results align with reports by organizations such as AthenaHealth and Planned Parenthood Federation of America that more women started requesting IUD inserts from their OB/GYNs and from Planned Parenthood community-based clinics after Donald Trump was elected president in early November.
Two of the firms that saw an increase in US sales for IUDs immediately after the election are Allergan...